The multipronged organization has a lab space on the working waterfront and an academy, the Gloucester Biotechnology Academy, ...

The Robert H. Lurie Comprehensive Cancer Center (Lurie Cancer Center) of Northwestern University was added as a second site in a clinical trial combining the LIXTE’s proprietary compound LB-100 with ...

Evommune (NYSE:EVMN) is a clinical-stage biotechnology company focused on developing therapies for chronic inflammatory ...

Evommune (NYSE:EVMN) is a clinical-stage biotechnology company focused on developing therapies for chronic inflammatory ...

LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing ...

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced it has filed its Annual Report on Form 10-K for the year ended Dec. 31, ...

Introduction: The upcoming ten years of innovation will establish their identity through the implementation of technological ...

Orano today announced that Frederic Desdouits has been appointed Chief Executive Officer of its subsidiary Orano Med, a ...

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced it has filed its Annual Report on Form 10-K for the year ended ...

From a sports scholarship to a higher doctorate of science, Athlone-born Neil Rowan has had an eventful career.

The National Testing Agency has opened the application correction window for the Graduate Aptitude Test-Biotechnology and ...